122 related articles for article (PubMed ID: 37358305)
1. Immunohistochemical analyses of neural stem cell lineage markers in normal feline brains and glial tumors.
Yoshida K; Chambers JK; Nibe K; Kagawa Y; Uchida K
Vet Pathol; 2024 Jan; 61(1):46-57. PubMed ID: 37358305
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
3. OLIG2 immunolabeling in feline ependymoma.
Demeter EA; Kent M; Glass EN; Rissi DR; Edwards J; Miller AD
J Vet Diagn Invest; 2022 Sep; 34(5):898-901. PubMed ID: 35762120
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
You H; Kim YI; Im SY; Suh-Kim H; Paek SH; Park SH; Kim DG; Jung HW
J Neurooncol; 2005 Aug; 74(1):1-8. PubMed ID: 16078101
[TBL] [Abstract][Full Text] [Related]
5. Ventricular and extraventricular ependymal tumors in 18 cats.
Woolford L; de Lahunta A; Baiker K; Dobson E; Summers BA
Vet Pathol; 2013 Mar; 50(2):243-51. PubMed ID: 22798290
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
[TBL] [Abstract][Full Text] [Related]
7. Vimentin and glial fibrillary acidic protein in human brain tumors.
Yung WK; Luna M; Borit A
J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
[TBL] [Abstract][Full Text] [Related]
8. SOX10 and Olig2 as negative markers for the diagnosis of ependymomas: An immunohistochemical study of 98 glial tumors.
Švajdler M; Rychlý B; Mezencev R; Fröhlichová L; Bednárová A; Pataky F; Daum O
Histol Histopathol; 2016 Jan; 31(1):95-102. PubMed ID: 26287936
[TBL] [Abstract][Full Text] [Related]
9. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
10. Subependymomas Are Low-Grade Heterogeneous Glial Neoplasms Defined by Subventricular Zone Lineage Markers.
D'Amico RS; Praver M; Zanazzi GJ; Englander ZK; Sims JS; Samanamud JL; Ogden AT; McCormick PC; Feldstein NA; McKhann GM; Sisti MB; Canoll P; Bruce JN
World Neurosurg; 2017 Nov; 107():451-463. PubMed ID: 28804038
[TBL] [Abstract][Full Text] [Related]
11. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
12. Canine Gliomatosis Cerebri: Morphologic and Immunohistochemical Characterization Is Supportive of Glial Histogenesis.
Rissi DR; Donovan TA; Porter BF; Frank C; Miller AD
Vet Pathol; 2021 Mar; 58(2):293-304. PubMed ID: 33357125
[TBL] [Abstract][Full Text] [Related]
13. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
Gottschalk J; Szymaś J
Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
[TBL] [Abstract][Full Text] [Related]
14. In vitro identification and functional characterization of glial precursor cells in human gliomas.
Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
[TBL] [Abstract][Full Text] [Related]
15. PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes.
Kanakasabai S; Pestereva E; Chearwae W; Gupta SK; Ansari S; Bright JJ
PLoS One; 2012; 7(11):e50500. PubMed ID: 23185633
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical analysis of intermediate filaments in human ependymal tumors.
Izukawa D; Lach B
Can J Neurol Sci; 1988 May; 15(2):114-8. PubMed ID: 2454716
[TBL] [Abstract][Full Text] [Related]
17. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors.
Azzarelli B; Miravalle L; Vidal R
J Neuropathol Exp Neurol; 2004 Feb; 63(2):170-9. PubMed ID: 14989603
[TBL] [Abstract][Full Text] [Related]
19. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
[TBL] [Abstract][Full Text] [Related]
20. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
